Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
(NASDAQ: CADL) Delayed: 11.02 -0.53 (4.59%)
Previous Close $11.55    52 Week High $ 
Open $11.50    52 Week Low $ 
Day High $11.55    P/E N/A 
Day Low $11.01    EPS $ 
Volume 799,738